Developer docs
API playgroundTry for free, no card

Search company profiles

KOEHLER eClinical

Full company profile

uuid002r25w

Namestring
KOEHLER eClinical
Legal namestring
Excelya Group
Company typeenum
Private
Founded yearint
1991
Descriptiontext

Data note: the firmographics block records KOEHLER eClinical as an 11–50 employee entity founded in 1991 in Freiburg, Germany, while the detailed source data describes Excelya, a private global CRO headquartered in Boulogne Billancourt, France. These profiles are internally inconsistent; the description below is anchored to the more substantive Excelya dataset.

Excelya is a privately held global Contract Research Organization (CRO) that operates a three-mode service architecture: Full Service, Functional Service Provider (FSP), and Clinical Resourcing. It serves Biotech, Pharma, and Medical Device organizations across six therapeutic areas — Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real-World Evidence. The company employs 1,000+ clinical research professionals across 16 offices in 25+ countries and has delivered 550+ clinical studies and 400+ clinical projects with a claimed 16% cost reduction.

The underlying technology stack centers on clinical operations and trial document management, with a best-in-class eTMF capability offering 100% digital trial document management and support for 3 of the 5 leading EDC systems. Integrated capabilities span Clinical Operations, Pharmacovigilance & Safety (24/7 drug safety monitoring), Data Management, eTMF Management, Medical Affairs (100+ experts, 100+ peer-reviewed publications), Statistics & Programming (150+ specialists, 25+ years of longest client partnerships in biometrics), Regulatory Affairs, and Quality Assurance. The company holds ISO 9001 and ISO 27001:2022 certifications, an EcoVadis Bronze sustainability rating, Veeva Services Partner status, and a 2025 French Government Gender Equality Index score of 97/100, reflecting enterprise-grade security, quality, and ESG positioning.

The revenue model is enterprise professional services and managed services under bespoke contracts; pricing is quote-based with no public disclosure. The go-to-market is direct enterprise field sales, anchored by long-duration engagements such as a 10-year pharmacovigilance partnership with UCB (announced 2026-05-26). Channels include industry conferences, case studies, press releases, and LinkedIn-led thought leadership. The firmographic record for KOEHLER eClinical (11–50 employees, founded 1991, Freiburg, Germany) is not corroborated by the detailed dataset and is treated here as a separate or stale record pending verification.

Short descriptiontext

KOEHLER eClinical per firmographics is a small German clinical research services provider; the substantive source data describes Excelya, a private global CRO delivering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device sponsors across 25+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFreiburg, Germany
HQ citystring
Freiburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, pharmacovigilance services, clinical data management, regulatory affairs consulting
Industry1 code
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services (CRO)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Full-Service CRO
TypeProfessional Services
Description

Expert guidance for clinical trial success, operating as one team with clients from protocol design to final report delivery

excelya.com
2Functional Service Provider (FSP)
TypeManaged Services
Description

One-team approach where Excelya shares responsibility for client outcomes, keeping projects on track, on time, and on budget

excelya.com
3Clinical Resourcing
TypeProfessional Services
Description

Talent pool solutions providing clinical research operations professionals to fill client needs

excelya.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

KOEHLER eClinical provides clinical research services to the biopharmaceutical industry and life science organizations. Based on the available source material, the company operates within the contract research organization (CRO) space, offering full-service clinical trial support, functional service provider (FSP) engagements, and clinical resourcing solutions spanning clinical operations, pharmacovigilance, data management, eTMF management, biostatistics, regulatory affairs, and medical writing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 16% cost reduction on clinical projects
+4 more records
Product overview1 text field

Excelya is a global full-service Contract Research Organization (CRO) offering a unique business model with three service modes: Full Service, Functional Service Provider (FSP), and Clinical Resourcing. The company provides integrated capabilities including Clinical Operations, Pharmacovigilance & Safety, Data Management, eTMF Management, Medical Affairs, Statistics & Programming, Regulatory Affairs, and Quality Assurance. Excelya specializes across six therapeutic areas: Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real-World Evidence. The integrated capabilities work together to support clients from protocol design to final report delivery.

Product and service3 records
1Full Service CRO
CategoryService Model
Description

End-to-end clinical trial management service delivering expert guidance from protocol design to final report, offered as a collaborative one-team model with clients for biotech, pharmaceutical, and medical device organizations.

2Functional Service Provider (FSP)
CategoryService Model
Description

FSP engagement model in which the provider shares responsibility for client outcomes, helping keep projects on track, on time, and on budget across functional areas of clinical development.

3Clinical Resourcing
CategoryService Model
Description

Talent-pool based resourcing service supplying clinical research operations professionals to fill client staffing needs across trials.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-26
Description

10-year pharmacovigilance partnership between Excelya and UCB, demonstrating long-term strategic relationship in drug safety and pharmacovigilance services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Full-service CRO with European roots delivering trials across oncology, hematology, rare disease and other specialties — closely comparable mid-market CRO profile and geographic orientation.

TypeBroad incumbent
Description

Largest global CRO with integrated R&D, technology, and data/analytics capabilities; relevant incumbent benchmark for the scale and platform breadth KOEHLER eClinical competes against.

TypeDirect peer
Description

Global full-service CRO with 1,000+ experts across 25+ countries offering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device clients — directly comparable service model and therapeutic coverage, though materially larger in scale than KOEHLER eClinical.

4KCR
TypeDirect peer
Description

European-headquartered mid-sized CRO providing clinical development and functional services across multiple therapeutic areas; similar niche positioning between global giants and small regional CROs that KOEHLER eClinical occupies.

5Cromsource
TypeDirect peer
Description

European CRO offering clinical research, staffing, and consulting services to pharma and biotech sponsors — comparable mid-market CRO with a similar mix of full-service and resourcing engagements.

TypeDirect peer
Description

Mid-sized global CRO focused on Phase II–III clinical development across CNS, cardiometabolic, oncology and rare disease; comparable therapeutic-area breadth and mid-market positioning.

TypeBroad incumbent
Description

One of the world's largest CROs offering full-service, FSP, and laboratory services; relevant incumbent demonstrating the scale tier KOEHLER eClinical would need to reach to compete for top-tier sponsor work.

TypeBroad incumbent
Description

Established mid-to-large CRO with strong therapeutic-area specialization model; relevant incumbent comparable on service mix though materially larger and publicly listed.

TypeEmerging player
Description

Mid-sized technology-enabled CRO offering full-service clinical development; comparable to KOEHLER eClinical in emphasizing eClinical / technology-augmented delivery for smaller to mid-sized sponsors.

TypeDirect peer
Description

Specialist CRO with strong pharmacovigilance and rare disease focus; comparable European mid-market CRO profile and therapeutic specialization overlap.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KOEHLER eClinical

Clinical Research Services (CRO)koehler-eclinical.com

KOEHLER eClinical per firmographics is a small German clinical research services provider; the substantive source data describes Excelya, a private global CRO delivering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device sponsors across 25+ countries.

What KOEHLER eClinical does

Data note: the firmographics block records KOEHLER eClinical as an 11–50 employee entity founded in 1991 in Freiburg, Germany, while the detailed source data describes Excelya, a private global CRO headquartered in Boulogne Billancourt, France. These profiles are internally inconsistent; the description below is anchored to the more substantive Excelya dataset.

Excelya is a privately held global Contract Research Organization (CRO) that operates a three-mode service architecture: Full Service, Functional Service Provider (FSP), and Clinical Resourcing. It serves Biotech, Pharma, and Medical Device organizations across six therapeutic areas — Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real-World Evidence. The company employs 1,000+ clinical research professionals across 16 offices in 25+ countries and has delivered 550+ clinical studies and 400+ clinical projects with a claimed 16% cost reduction.

The underlying technology stack centers on clinical operations and trial document management, with a best-in-class eTMF capability offering 100% digital trial document management and support for 3 of the 5 leading EDC systems. Integrated capabilities span Clinical Operations, Pharmacovigilance & Safety (24/7 drug safety monitoring), Data Management, eTMF Management, Medical Affairs (100+ experts, 100+ peer-reviewed publications), Statistics & Programming (150+ specialists, 25+ years of longest client partnerships in biometrics), Regulatory Affairs, and Quality Assurance. The company holds ISO 9001 and ISO 27001:2022 certifications, an EcoVadis Bronze sustainability rating, Veeva Services Partner status, and a 2025 French Government Gender Equality Index score of 97/100, reflecting enterprise-grade security, quality, and ESG positioning.

The revenue model is enterprise professional services and managed services under bespoke contracts; pricing is quote-based with no public disclosure. The go-to-market is direct enterprise field sales, anchored by long-duration engagements such as a 10-year pharmacovigilance partnership with UCB (announced 2026-05-26). Channels include industry conferences, case studies, press releases, and LinkedIn-led thought leadership. The firmographic record for KOEHLER eClinical (11–50 employees, founded 1991, Freiburg, Germany) is not corroborated by the detailed dataset and is treated here as a separate or stale record pending verification.

KOEHLER eClinical firmographics

Firmographics
Name
KOEHLER eClinical
Legal name
Excelya Group
Website
https://koehler-eclinical.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
KOEHLER eClinical per firmographics is a small German clinical research services provider; the substantive source data describes Excelya, a private global CRO delivering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device sponsors across 25+ countries.
Ownership category
akta.pro rank

KOEHLER eClinical industry classification

Industry
Product category
Clinical Research Services (CRO)
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)

Keywords

  • Clinical research services
  • Contract research organization
  • Pharmacovigilance services
  • Clinical data management
  • Regulatory affairs consulting

Where KOEHLER eClinical is headquartered

Location

Headquarters

HQ city
Freiburg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

KOEHLER eClinical business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Full-Service CRO: Expert guidance for clinical trial success, operating as one team with clients from protocol design to final report delivery
  2. Functional Service Provider (FSP): One-team approach where Excelya shares responsibility for client outcomes, keeping projects on track, on time, and on budget
  3. Clinical Resourcing: Talent pool solutions providing clinical research operations professionals to fill client needs

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

KOEHLER eClinical product offering

Product offering

Core offering

KOEHLER eClinical provides clinical research services to the biopharmaceutical industry and life science organizations. Based on the available source material, the company operates within the contract research organization (CRO) space, offering full-service clinical trial support, functional service provider (FSP) engagements, and clinical resourcing solutions spanning clinical operations, pharmacovigilance, data management, eTMF management, biostatistics, regulatory affairs, and medical writing.

Product overview

Excelya is a global full-service Contract Research Organization (CRO) offering a unique business model with three service modes: Full Service, Functional Service Provider (FSP), and Clinical Resourcing. The company provides integrated capabilities including Clinical Operations, Pharmacovigilance & Safety, Data Management, eTMF Management, Medical Affairs, Statistics & Programming, Regulatory Affairs, and Quality Assurance. Excelya specializes across six therapeutic areas: Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real-World Evidence. The integrated capabilities work together to support clients from protocol design to final report delivery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Full Service CRO End-to-end clinical trial management service delivering expert guidance from protocol design to final report, offered as a collaborative one-team model with clients for biotech, pharmaceutical, and medical device organizations.
  • Functional Service Provider (FSP) FSP engagement model in which the provider shares responsibility for client outcomes, helping keep projects on track, on time, and on budget across functional areas of clinical development.
  • Clinical Resourcing Talent-pool based resourcing service supplying clinical research operations professionals to fill client staffing needs across trials.

Quantifiable outcome

  • 16% cost reduction on clinical projects
  • +4 more outcomes

Companies that use KOEHLER eClinical

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

KOEHLER eClinical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

KOEHLER eClinical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • UCBcoreStrategic or Co-development Partner · 26 May 202610-year pharmacovigilance partnership between Excelya and UCB, demonstrating long-term strategic relationship in drug safety and pharmacovigilance services.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

KOEHLER eClinical competitors and assessment

Company assessment

Direct peers

  • PSI CRO: Full-service CRO with European roots delivering trials across oncology, hematology, rare disease and other specialties — closely comparable mid-market CRO profile and geographic orientation.
  • Excelya: Global full-service CRO with 1,000+ experts across 25+ countries offering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device clients — directly comparable service model and therapeutic coverage, though materially larger in scale than KOEHLER eClinical.
  • KCR: European-headquartered mid-sized CRO providing clinical development and functional services across multiple therapeutic areas; similar niche positioning between global giants and small regional CROs that KOEHLER eClinical occupies.
  • Cromsource: European CRO offering clinical research, staffing, and consulting services to pharma and biotech sponsors — comparable mid-market CRO with a similar mix of full-service and resourcing engagements.
  • Worldwide Clinical Trials: Mid-sized global CRO focused on Phase II–III clinical development across CNS, cardiometabolic, oncology and rare disease; comparable therapeutic-area breadth and mid-market positioning.
  • Ergomed: Specialist CRO with strong pharmacovigilance and rare disease focus; comparable European mid-market CRO profile and therapeutic specialization overlap.

Broad incumbents

  • IQVIA: Largest global CRO with integrated R&D, technology, and data/analytics capabilities; relevant incumbent benchmark for the scale and platform breadth KOEHLER eClinical competes against.
  • ICON plc: One of the world's largest CROs offering full-service, FSP, and laboratory services; relevant incumbent demonstrating the scale tier KOEHLER eClinical would need to reach to compete for top-tier sponsor work.
  • Medpace: Established mid-to-large CRO with strong therapeutic-area specialization model; relevant incumbent comparable on service mix though materially larger and publicly listed.

Emerging players

  • Clinipace Worldwide: Mid-sized technology-enabled CRO offering full-service clinical development; comparable to KOEHLER eClinical in emphasizing eClinical / technology-augmented delivery for smaller to mid-sized sponsors.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat6 records

Key risks4 records

Key highlights4 records

Customer concentration

KOEHLER eClinical social profiles

Digital presence

KOEHLER eClinical compliance and trust

Trust signal

Compliance4 records

KOEHLER eClinical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KOEHLER eClinical leadership team

Management profile

Number of profiles

KOEHLER eClinical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KOEHLER eClinical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KOEHLER eClinical

What does KOEHLER eClinical do?

KOEHLER eClinical provides clinical research services to the biopharmaceutical industry and life science organizations. Based on the available source material, the company operates within the contract research organization (CRO) space, offering full-service clinical trial support, functional service provider (FSP) engagements, and clinical resourcing solutions spanning clinical operations, pharmacovigilance, data management, eTMF management, biostatistics, regulatory affairs, and medical writing.

Is KOEHLER eClinical a public or private company?

KOEHLER eClinical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was KOEHLER eClinical founded?

KOEHLER eClinical was founded in 1991. It employs 11 to 50 people.

Where is KOEHLER eClinical based?

KOEHLER eClinical is headquartered in Freiburg, Germany, in the Europe region.

How does KOEHLER eClinical make money?

Three revenue lines are on record. Full-Service CRO is the primary driver. The others are functional Service Provider (FSP) and clinical Resourcing.

Who are KOEHLER eClinical's main competitors?

Direct peers on record are PSI CRO, Excelya, KCR, Cromsource, Worldwide Clinical Trials and Ergomed. Broad incumbents are IQVIA, ICON plc and Medpace. Clinipace Worldwide is listed as an emerging player.

Does KOEHLER eClinical have an API?

No public API is recorded for KOEHLER eClinical.

What industry is KOEHLER eClinical in?

KOEHLER eClinical's product category is Clinical Research Services (CRO). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales